Chronic Myelogenous Leukemia research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE4
Asciminib Roll-over Study
This study is for people who have already been taking a medicine called asciminib (or similar drugs) in a Novartis study for a type of blood cancer called CML. It allows them to keep taking the medicine if their doctor thinks it's still helping them.
United States · Argentina · Austria - ongoing, recruitingTherapeutic exploratory (Phase II)
Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Reinduction and second stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
This study looks at people with a type of blood cancer called CML who are doing well on a drug called Iclusig. It aims to see if they can safely stop Iclusig after taking it again, and how long they stay well without treatment.
Spain - recruitingPHASE2
Methods of T Cell Depletion Trial (MoTD)
This study compares different ways to prevent a complication called GvHD after stem cell transplants for various blood cancers. It's looking for the best treatment plan to help patients recover well, using common medicines like Thymoglobulin, Cyclophosphamide, Cyclosporine, Sirolimus, and Mycophenolate Mofetil.
United Kingdom